en · de · es · pt
cardarine-notes.peptides6823.com › Guide › Background And Research Context — Explained

Background And Research Context — Explained

By Editorial Desk · published 2025-11-28 · last reviewed 2026-01-03 · Guide

Preclinical research comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.

Updated 2026-01-03. Numbers and descriptions here follow the published literature rather than marketing material.

Background and Research Context

PPARδ is a nuclear receptor that regulates gene expression related to fatty acid oxidation, glucose homeostasis, and mitochondrial function. GW501516 binds to this receptor with high affinity and activates downstream signaling in skeletal muscle and other tissues. Animal studies reported increased endurance and altered fuel preference, but human data remain limited and inconsistent. The precise relationship between receptor activation and observed physiological changes is still an area of active investigation. Researchers have also examined whether the compound affects inflammation or cell proliferation. No approved therapeutic indication exists for cardarine.

In laboratory settings, cardarine is studied as a tool compound for probing PPARδ biology. Published experiments often use cell cultures, rodent models, or isolated tissues. Some investigations focus on metabolic effects, while others assess potential risks such as carcinogenicity observed in long-term animal studies. Because human trials are sparse, most knowledge comes from preclinical work and adverse event reports. Scientific literature frequently notes the gap between animal findings and human outcomes. The compound is not a dietary supplement and is not intended for human consumption.

Identity and Regulatory Status

Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.

Regulatory treatment varies, but cardarine is not approved as a medicine. Sports authorities list GW501516 as a prohibited substance, and it is banned at all times under the World Anti-Doping Agency code. Many countries restrict sales for human consumption, while online vendors market it as a research chemical. Such products may lack purity data, and their actual contents can differ from the label. Purchasing or possessing cardarine may carry legal consequences depending on jurisdiction. The compound is not a dietary supplement ingredient in regulated markets.

Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.

Cardarine at a glance

PropertyValueNotes
CAS Registry Number317318-70-0Unique identifier for the compound.
Chemical classPPARδ agonistSynthetic ligand for peroxisome proliferator-activated receptor delta.
AppearanceWhite to off-white solidTypical form of research-grade material.
SolubilitySoluble in DMSO and ethanolPoorly soluble in water.
Typical storage-20°CRecommended for long-term storage of stock solutions.

Identity and Pharmacological Classification

Cardarine is a common name for GW501516, also GW-1516, a synthetic compound developed as a peroxisome proliferator-activated receptor delta (PPARδ) agonist. It belongs to a class of agents that modulate gene transcription related to lipid and energy metabolism. The compound was studied in preclinical and early clinical research for metabolic and cardiovascular conditions, but it did not progress to approved therapeutic use. Its name appears in fitness and sports contexts despite not being approved as a drug.

PPARδ is a nuclear receptor that influences transcription of genes involved in fatty acid oxidation, lipid transport, and energy homeostasis. GW501516 binds and activates this receptor with high selectivity relative to PPARα and PPARγ in laboratory assays. Activation alters expression of target genes in skeletal muscle, liver, and adipose tissue in animal models. The exact clinical consequences of these changes in humans remain incompletely characterized, and observed effects in animals do not establish therapeutic benefit or safety.

Published studies have examined GW501516 in animal models of obesity, insulin resistance, and exercise endurance. Early human trials reportedly ended, and development was discontinued after preclinical findings raised concerns about cancer in some rodent studies. Regulatory agencies have not approved cardarine for any medical use. Its availability through non-pharmaceutical channels raises questions about identity, purity, and legal status that are separate from its laboratory pharmacology. Those questions are often addressed through analytical testing rather than assumptions about product labels.

Related pages on this site

Cardarine Identity and Mechanism

Cardarine is the common name for GW501516, a synthetic compound studied as a peroxisome proliferator-activated receptor delta agonist. Researchers developed it to explore treatments for lipid disorders and metabolic conditions. It is not an approved medicine in any country. Early clinical work examined changes in HDL cholesterol and triglycerides, but development was discontinued after animal studies raised concerns about cancer. The compound remains available as a research chemical and appears in discussions of performance enhancement.

At the molecular level, GW501516 binds and activates PPARδ, a nuclear receptor that regulates transcription. Activation shifts expression of genes involved in fatty acid oxidation, energy expenditure, and lipid transport in skeletal muscle and liver. Animal studies report increased endurance and altered lipid profiles after exposure. Human data are limited to small trials and do not establish long-term safety or efficacy. PPARδ also has roles in cell proliferation, so the relationship between activation and cancer risk remains an open question.

Notes from published material

The concept of a "Fortress North America" emerged during the Second World War and persisted into the Cold War to refer to the option of defending Canada and the United States against their enemies if the rest of the world were lost to them. This option was rejected with the formation of NATO and the decision to permanently station troops in Europe. In the summer of 1951, Project Vista started, in which project analysts such as Robert F. Christy looked at how to defend Western Europe from a Soviet invasion. The emerging development of tactical nuclear weapons was looked upon as a means to give Western forces a qualitative advantage over the Soviet numerical supremacy in conventional weapons. Several scares about the increasing ability of the Soviet Union's strategic bomber forces surfaced during the 1950s. The defensive response by the United States was to deploy a fairly strong "layered defense" consisting of interceptor aircraft and anti-aircraft missiles, like the Nike, and guns, like the M51 Skysweeper, near larger cities. However, this was a small response compared to the construction of a huge fleet of nuclear bombers. The principal nuclear strategy was to massively penetrate the Soviet Union. Because such a large area could not be defended against this overwhelming attack in any credible way, the Soviet Union would lose any exchange. This logic became ingrained in American nuclear doctrine and persisted for much of the duration of the Cold War.

=== Immunology and neurobiology === Hood also made generative discoveries in the field of molecular immunology. His studies of the amino acid sequences of immunoglobulins (also known as antibodies) helped to fuel the 1970s' debate regarding the generation of immune diversity and supported the hypothesis advanced by William J. Dreyer that immunoglobulin (antibody) chains are encoded by two separate genes (a constant and a variable gene). He (and others) conducted pioneering studies on the structure and diversity of the antibody genes. This research led to verification of the "two genes, one polypeptide" hypothesis and insights into the mechanisms responsible for the diversification of the immunoglobulin variable genes. Hood shared the Lasker Award in 1987 for these studies. Additionally, Hood was among the first to study, at the gene level, the MHC (major histocompatibility complex) gene family and the T-cell receptor gene families as well as being among first to demonstrate that alternative RNA splicing was a fundamental mechanism for generating alternative forms of antibodies. He showed that RNA splicing is the mechanism for generating the membrane bound and the secreted forms of antibodies. In neurobiology, Hood and his colleagues were the first to clone and study the myelin basic protein (MBP) gene. The MBP is a central component in the sheath that wraps and protects neurons. Hood demonstrated that the condition called "shiverer mouse" arose from a defect in the MBP gene.

Commonly used for multilayer coating in the photographic industry. Slot die bead coating – typically with the web backed by a roller and a very small gap between slot-die and web. Tensioned-web slot-die coating – with no backing for the web. Inkjet printing Lithography Flexography

Sources: en.wikipedia.org

Background from the literature

Commercial airliners typically cruise at altitudes of 9–12 km (30,000–39,000 ft) which is in the lower reaches of the stratosphere in temperate latitudes. This optimizes fuel efficiency, mostly due to the low temperatures encountered near the tropopause and low air density, reducing parasitic drag on the airframe. Stated another way, it allows the airliner to fly faster while maintaining lift equal to the weight of the plane. (The fuel consumption depends on the drag, which is related to the lift by the lift-to-drag ratio.) It also allows the airplane to stay above the turbulent weather of the troposphere. The Concorde aircraft cruised at Mach 2 at about 60,000 ft (18 km), and the SR-71 cruised at Mach 3 at 85,000 ft (26 km), all within the stratosphere. Because the temperature in the tropopause and lower stratosphere is largely constant with increasing altitude, very little convection and its resultant turbulence occurs there. Most turbulence at this altitude is caused by variations in the jet stream and other local wind shears, although areas of significant convective activity (thunderstorms) in the troposphere below may produce turbulence as a result of convective overshoot. On October 24, 2014, Alan Eustace became the record holder for reaching the altitude record for a manned balloon at 135,890 ft (41,419 m). Eustace also broke the world records for vertical speed skydiving, reached with a peak velocity of 1,321 km/h (822 mph) and total freefall distance of 123,414 ft (37,617 m), lasting 4 minutes and 27 seconds.

Clindamycin/benzoyl peroxide, sold under the brand name Benzaclin among others, is a topical gel used for the treatment of acne. It is a fixed-dose combination of clindamycin, as the phosphate, an antibiotic; and benzoyl peroxide, an antiseptic. Common side effects include peeling, itching, and dryness of the skin where the gel was applied. Clindamycin/benzoyl peroxide was approved for medical use in the United States in December 2000. It is available as a generic medication.

During the period he was Labour MP for Glasgow Kelvin, from 1997 to 2003, he voted against the whip 32 times, five votes out of 665 (0.8%) in the 1997–2001 parliament and the majority (27 votes out of 209 or 12.9%) in the period from the 2001 election until his expulsion from the Labour Party. He was one of several politicians arrested in February 2001 during a protest at the Faslane nuclear base in Scotland, which led to him being convicted of a breach of the peace and fined £180. In May 2002, he was among the 72 MPs who signed The Guardian's campaign to repeal the Act of Settlement 1701, alongside the Archbishop of York David Hope and several non-Anglican religious leaders.

Sources: en.wikipedia.org

Further detail

Saint-Simon was fascinated by the enormous potential of science and technology and advocated a socialist society that would eliminate the disorderly aspects of capitalism and would be based on equal opportunities. He advocated the creation of a society in which each person was ranked according to his or her capacities and rewarded according to his or her work. The key focus of Saint-Simon's socialism was on administrative efficiency and industrialism and a belief that science was the key to the progress of human civilisation. This was accompanied by a desire to implement a rationally organised economy based on planning and geared towards large-scale scientific progress and material progress, embodying a desire for a more directed or planned economy. The term "socialism" was first used in English in the British Cooperative Magazine in 1827 and came to be associated with the followers of Owen such as the Rochdale Pioneers, who founded the co-operative movement. Owen's followers stressed both participatory democracy and economic socialisation in the form of consumer co-operatives, credit unions, and mutual aid societies. In the case of the Owenites, they also overlapped with a number of other working-class and labour movements such as the Chartists in the United Kingdom.

=== Structural domains === Full-length CCN1 protein contains 381 amino acids with an N-terminal secretory signal peptide followed by four structurally distinct domains. The four CCN1 domains are, from N- to C-termini, the insulin-like growth factor binding protein (IGFBP) domain, von Willebrand type C repeats (vWC) domain, thrombospondin type 1 repeat domain (TSR), and the C-terminal (CT) domain that contains a cysteine-knot motif. CCN1 has unusually high cysteine residue content (10% or 38 in total). The number and spacing of cysteine residues are completely conserved among CCN1, CTGF (CCN2), NOV (CCN3), and WISP-1 (CCN4), and are largely conserved with WISP-2 (CCN5), which lacks precisely the CT domain, and WISP3 (CCN6), which lacks 4 cysteines in the vWC domain. CCN1 is glycosylated, although the regulation and function of glycosylation are unknown.

==== Economists and entrepreneurs ==== Many business groups in India are welcoming the transformation of a long-protected sector that has left Indian shoppers bereft of the scale and variety of their counterparts in more developed markets. B. Muthuraman, the president of the Confederation of Indian Industry, claimed the retail reform would open enormous opportunities and lead to much-needed investment in cold chain, warehousing and contract farming. Organised retailers will reduce waste by improving logistics, creating cold storage to prevent food spoilage, improve hygiene and product safety, reduce counterfeit trade and tax evasion on expensive item purchases, and create dependable supply chains for secure supply of food staples, fruits and vegetables. They will increase choice and reduce India's rampant inflation by reducing waste, spoilage and cutting out middlemen. Fresh investment in organised retail, the supporters of retail reform claim will generate 10 million new jobs by 2014, about five to six million of them in logistics alone.To address these infrastructure gaps, some Indian retailers have adopted vertical SaaS platforms for inventory optimization; for example, platforms like Increff provide automated merchandising and supply chain solutions aimed at reducing stockouts. Organised retail will offer the small Indian farmer more competing venues to sell his or her products, and increase income from less spoilage and waste.

Sources: en.wikipedia.org

Frequently asked questions

What is cardarine?

Cardarine is a common name for GW501516, a synthetic PPARδ agonist developed for research. It has not been approved as a medication in any country. It is classified as an unapproved drug and a prohibited substance in sport.

Is cardarine a steroid?

No. Cardarine is not an anabolic steroid; it belongs to a different chemical class that targets PPARδ. Steroids act primarily through androgen receptors, while cardarine acts through a nuclear receptor involved in metabolism.

What did animal studies find?

Some rodent studies reported increased endurance and changes in fat metabolism after cardarine exposure. Long-term studies in animals also raised concerns about cancer in certain tissues. Human trial data are limited, so these findings cannot be directly translated to people.

Is cardarine a SARM?

No. Cardarine is GW501516, a PPARδ agonist, while SARMs act on androgen receptors. The two classes are often grouped in informal discussions despite different mechanisms.

Network